Skip to main content
. 2024 Feb 23;32(3):185. doi: 10.1007/s00520-024-08396-4

Table 2.

The number of subjects with oral Candida carriage pre-HSCT and 3, 6, 12, and 24 months post-HSCT

Subjects Pre-HSCT 3 M 6 M 12 M 24 M
Female; # of candida/ # of subjects; (%) 23/82 (28.1%) 10/38 (26.3%) 12/38 (31.6%) 13/33 (39.4%) 4/9 (44.4%)
Male; # of candida/ # of subjects (%) 37/118 (31.4%) 12/48 (25.0%) 18/47 (38.3%) 20/42 (47.6%) 4/8 (50.0%)
Total; # of candida/ # of subjects (%) 60/200 (30.0%) 22/86 (25.6%) 30/85 (35.3%) 33/75 (44. 0%) 8/17 (47.1%)